Furthermore, a small retrospective study suggested a KL-6 serum level >2000 U/mL in SSc patients under treatment (corticoids and cyclophosphamide) was indicative of poor therapeutic response [141]. The gene discussed is MUC1; the disease is systemic sclerosis.